PL373346A1 - Nowe, rozpuszczalne w wodzie związki porfirynoplatyny o wysokiej selektywności względem nowotworów i ich zastosowanie w leczeniu łagodnych i złośliwych chorób nowotworowych - Google Patents

Nowe, rozpuszczalne w wodzie związki porfirynoplatyny o wysokiej selektywności względem nowotworów i ich zastosowanie w leczeniu łagodnych i złośliwych chorób nowotworowych

Info

Publication number
PL373346A1
PL373346A1 PL03373346A PL37334603A PL373346A1 PL 373346 A1 PL373346 A1 PL 373346A1 PL 03373346 A PL03373346 A PL 03373346A PL 37334603 A PL37334603 A PL 37334603A PL 373346 A1 PL373346 A1 PL 373346A1
Authority
PL
Poland
Prior art keywords
benign
treatment
water
platinum compounds
porphyrin platinum
Prior art date
Application number
PL03373346A
Other languages
English (en)
Inventor
Karl-Christian Bart
Günther Bernhardt
Henri Brunner
Christian Lottner
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PL373346A1 publication Critical patent/PL373346A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03373346A 2002-02-01 2003-01-29 Nowe, rozpuszczalne w wodzie związki porfirynoplatyny o wysokiej selektywności względem nowotworów i ich zastosowanie w leczeniu łagodnych i złośliwych chorób nowotworowych PL373346A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35358502P 2002-02-01 2002-02-01

Publications (1)

Publication Number Publication Date
PL373346A1 true PL373346A1 (pl) 2005-08-22

Family

ID=27663224

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373346A PL373346A1 (pl) 2002-02-01 2003-01-29 Nowe, rozpuszczalne w wodzie związki porfirynoplatyny o wysokiej selektywności względem nowotworów i ich zastosowanie w leczeniu łagodnych i złośliwych chorób nowotworowych

Country Status (18)

Country Link
US (1) US7087214B2 (pl)
EP (1) EP1470139A2 (pl)
JP (1) JP2005522429A (pl)
KR (1) KR20040083098A (pl)
CN (1) CN1303090C (pl)
AR (1) AR038479A1 (pl)
BR (1) BR0307400A (pl)
CA (1) CA2418410A1 (pl)
HR (1) HRP20040788A2 (pl)
MX (1) MXPA04007443A (pl)
NO (1) NO20043650L (pl)
NZ (1) NZ534541A (pl)
PL (1) PL373346A1 (pl)
RU (1) RU2004126637A (pl)
TW (1) TWI233929B (pl)
UA (1) UA78007C2 (pl)
WO (1) WO2003064424A2 (pl)
ZA (1) ZA200405925B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
EP1950217A1 (en) * 2007-01-26 2008-07-30 Université de Neuchâtel Organometallic compounds for the treatment of cancer
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
EP2526103B1 (en) * 2010-01-22 2016-05-04 Council of Scientific & Industrial Research A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes
CN102408452B (zh) * 2011-12-13 2014-09-03 中山大学 四吡啶基卟啉桥联十字形四核铂配合物及其制备方法和抗肿瘤活性
BR112015023568B8 (pt) 2013-03-15 2024-01-02 Ann Mcfarland Sherri Composto à base de metal como composto fotodinâmico
WO2019217606A1 (en) * 2018-05-09 2019-11-14 Virginia Commonwealth University Near-ir activatable fluorescent small molecules with dual modes of cytotoxicity
CN109251206B (zh) * 2018-09-21 2022-02-08 上海大学 水溶性铂-卟啉配合物及其制备方法
CN110028513B (zh) * 2019-04-30 2020-12-11 北京太阳升高科医药研究股份有限公司 卟啉衍生物及声敏剂
CN110590852B (zh) * 2019-08-29 2022-12-09 合肥学院 一种具有抗肿瘤活性的铂配合物及其制备方法
CN120381439B (zh) * 2025-02-24 2026-04-24 苏州大学 一种基于吡啶基卟啉的聚乙二醇化的纳米颗粒及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615545B2 (ja) * 1984-10-01 1994-03-02 東洋薄荷工業株式会社 金属フェオホーバイド誘導体および金属ポルフィリン誘導体
ZA86704B (en) 1985-02-23 1986-10-29 Asta Werke Ag Chem Fab Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
KR910009202B1 (ko) * 1985-10-23 1991-11-04 니혼메디피직스 가부시끼가이샤 포르피린 유도체의 제조방법
DE19824653A1 (de) 1998-02-25 1999-08-26 Schering Ag Nekrose-affine Verbindungen und ihre Verwendung zur Herstellung von Präparaten zur Pharmakotherapie

Also Published As

Publication number Publication date
HRP20040788A2 (en) 2004-12-31
MXPA04007443A (es) 2004-10-11
KR20040083098A (ko) 2004-09-30
NO20043650L (no) 2004-10-29
AR038479A1 (es) 2005-01-19
ZA200405925B (en) 2004-09-07
CN1303090C (zh) 2007-03-07
BR0307400A (pt) 2004-12-21
US7087214B2 (en) 2006-08-08
CA2418410A1 (en) 2003-08-01
EP1470139A2 (en) 2004-10-27
UA78007C2 (en) 2007-02-15
NZ534541A (en) 2005-10-28
TWI233929B (en) 2005-06-11
WO2003064424A3 (en) 2004-01-15
RU2004126637A (ru) 2006-02-10
HK1078585A1 (en) 2006-03-17
WO2003064424A2 (en) 2003-08-07
US20040023942A1 (en) 2004-02-05
CN1639178A (zh) 2005-07-13
JP2005522429A (ja) 2005-07-28
TW200305571A (en) 2003-11-01

Similar Documents

Publication Publication Date Title
AU2003302892A8 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004045516A9 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1587837A3 (en) Prostate cancer diagnosis and treatment
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004060270A8 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200402319B (en) Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer.
WO2003057160A8 (en) Compositions and methods for the diagnosis and treatment of tumor
PL373912A1 (pl) Heterocykliczne pochodne do leczenia raka i innych chorób proliferacyjnych
IL162201A0 (en) New methods for diagnosis and treatment of tumours
PL375527A1 (pl) Arylokarbonylopiperazyny i heteroarylokarbonylopiperazyny oraz ich zastosowanie do leczenia łagodnych i złośliwych chorób nowotworowych
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
PL373346A1 (pl) Nowe, rozpuszczalne w wodzie związki porfirynoplatyny o wysokiej selektywności względem nowotworów i ich zastosowanie w leczeniu łagodnych i złośliwych chorób nowotworowych
IL161059A0 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
MXPA03003011A (es) Metodos para inducir muerte de celulas cancerosas y regresion de tumores.
WO2005003154A8 (en) Compositions and methods for the diagnosis and treatment of tumor
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
AU2003263036A8 (en) Span-xb gene and protein for the diagnosis and treatment of cancer
ZA200604365B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1684795A4 (en) METHODS AND AGENTS FOR THE TREATMENT OF CANCER

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)